Lesson 2

Cards (63)

  • Pathophysiology
    The study of functional or physiologic changes in the body that result from disease processes
  • Aspects of pathophysiology
    • Etiology
    • Pathogenesis
    • Changes
    • Manifestations
    • Normal body function (physiology)
    • Homeostasis
  • Health
    The state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity
  • Adaptation
    The reversible functional and structural responses to changes in physiologic states and some pathologic stimuli, during which new but altered steady states are achieved, allowing the cell to survive and continue to function
  • Injury
    The sequence of events that follows once the limits of adaptive responses have exceeded or if cells are exposed to injurious agents or stress, deprived of essential nutrients, or become compromised by mutations that affect essential cellular constituents
  • Pathogenesis
    The development of the disease or the sequence of events involved in the tissue changes related to the specific disease process
  • Diagnosis
    Identification of a specific disease through evaluation of signs and symptoms, laboratory tests, and other tools
  • Etiology
    The causative factor(s) in a particular disease - genetic, congenital defects, microorganisms, immunologic dysfunction, metabolic derangements, degenerative diseases, malignancy, environmental, and nutritional deficiency
  • Idiopathic
    Unknown cause
  • Iatrogenic
    Diseases caused by error in the treatment, procedure etc.
  • Predisposing (risk) factor
    Tendencies that promote development of disease
  • Prophylaxis
    Preventive measures to preserve health and spread of disease - intake of certain medications, and undergoing medical procedures
  • Prevention
    Strategies and measures that lowers the risk for development or exposure from the disease, thereby preserving health - vaccination, dietary and lifestyle modifications, removal of harmful objects in the environment, cessation of harmful activities (i.e., smoking, alcohol drinking, use of drugs)
  • Pathogenesis
    The sequence of cellular, biochemical, and molecular events that follow the exposure of cells or tissues to an injurious agent
  • Morphologic changes

    Structural alterations in cells or tissues that are either characteristic of a disease or diagnostic of an etiologic process
  • Clinical manifestations
    External features seen among patients as end results of genetic, biochemical, and structural changes in cells and tissues (functional abnormalities)
  • Diagnostic test
    Laboratory tests that assist in the diagnosis and monitoring of a specific disease using samples taken from the patient - blood, body fluids, tissue specimen, and secretions
  • Precipitating factor
    Condition that triggers an acute episode
  • Therapy
    Treatment measures used to promote recovery or slow the progress of a disease - surgery, drugs, physiotherapy, alternatives, behavioral change
  • Prognosis
    The probability or likelihood for recovery or other outcomes
  • Sequelae
    Potential unwanted outcomes of the primary condition
  • Complications
    New secondary or additional problems that arise after the original disease begins
  • Characteristics of disease
    • Onset
    • Duration (chronicity)
    • Stage
    • Course
    • Clinical picture
    • Outcome
  • Hypertrophy
    An increase in the size of cells, that results in an increase in the size of the affected organ
  • Physiologic hypertrophy

    Caused by increased functional demand or by stimulation by hormones and growth factors (i.e., increased workload, pregnancy)
  • Pathologic hypertrophy
    Caused by increased functional demand or by stimulation but reaches beyond the reversible point and the organ becomes dysfunctional
  • Hyperplasia
    An increase in the number of cells in an organ or tissue in response to a stimulus
  • Physiologic hyperplasia
    Due to the action of hormones or growth factors, occurs in several circumstances: when there is a need to increase functional capacity of hormone sensitive organs; when there is need for compensatory increase after damage or resection
  • Pathologic hyperplasia
    Mostly caused by excessive or inappropriate actions of hormones or growth factors acting on target cells - endometrial hyperplasia, BPH
  • Atrophy
    Reduction in size of organ or tissue due to a decrease in cell size and number
  • Physiologic atrophy
    • Notochord and thyroglossal duct undergo atrophy during fetal development
  • Pathologic atrophy
    • Decreased workload (atrophy of disuse)
    • Loss of innervation (denervation atrophy)
  • Causes of atrophy
    1. Decreased protein synthesis
    2. Increased protein degradation
    3. Fewer mitochondria, myofilaments, RER
    4. Reduced blood supply
    5. Lesser metabolic demand
  • Early atrophic cells and tissues have diminished function, but cell death is minimal
  • Nutrient deficiency and disuse may activate ubiquitin ligases, which attach the small peptide ubiquitin to cellular proteins and target these proteins for degradation in proteasomes and even autophagy
  • Physiologic atrophy
    • Common during normal development
    • Notochord and thyroglossal duct undergo atrophy during fetal development
  • Causes of pathologic atrophy
    • Decreased workload (atrophy of disuse)
    • Loss of innervation (denervation atrophy)
    • Diminished blood supply
    • Inadequate nutrition
    • Loss of endocrine stimulation
    • Pressure
  • Metaplasia
    Reversible change in which one differentiated cell type (epithelial or mesenchymal) is replaced by another cell type
  • Metaplasia
    Represents an adaptive response in which one cell type that is sensitive to a particular stress is replaced by another cell type that is better able to withstand the adverse environment
  • Metaplasia does not result from a change in the phenotype of an already differentiated cell type; instead it is the result of a reprogramming of stem cells that are known to exist in normal tissues, or of undifferentiated mesenchymal cells present in connective tissue